ArticleiScience2026
Sex differences in gene regulation and its impact on cancer incidence.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Leiomodin 1 deficiency promotes lipid accumulation and redirects gene regulatory programs in smooth muscle cells exposed to oxidized LDL.Research square · 2026Article
- The Non-Coding rs5945619 Variant at Xp11.22 and Its Putative Regulatory Effects on Nearby Genes in Ecuadorian Mestizo Women with Breast Cancer: A Case Series and In Silico Cis-eQTL Analysis.International journal of molecular sciences · 2026Article
- Lung cancer in women emerges as a distinct disease.Nature · 2026Article
Corrections and comments
- Update of
Authors and funding
9 authors.
Funding
Abstract
There are significant sex differences in cancer incidence, yet the underlying regulatory mechanisms in normal tissues remain poorly understood. We studied 8,279 gene regulatory networks across 29 non-cancerous tissues and compared network centrality by sex. Cancer genes were differentially targeted by transcription factors in males and females, with an overrepresentation on the X chromosome, particularly among X-inactivation escapees, and key signaling pathways such as WNT, NOTCH, and p53. We observed higher targeting of cancer-related pathways in females for tissues that have higher tumor incidence in females (breast, lung, and thyroid) and higher targeting in males for tissues with increased tumor incidence in males (stomach, colon, and liver), a pattern replicated in independent lung data. Sex-biased transcription factors were enriched for sex hormone response elements. These findings suggest that sex-biased transcriptional programs in normal tissues contribute to sex differences in cancer incidence and should be considered in cancer prevention strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.